IRVINE, Calif., Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 2,575,107 units at a public offering price of $2.33 per unit. Each unit consists of one common share (or pre-funded warrant to…
Fri, 09 May 2025 16:45:00 GMT May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors ...
Wed, 07 May 2025 05:32:00 GMT IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors ...
Wed, 07 May 2025 01:31:00 GMT May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors ...
Tue, 06 May 2025 17:00:00 GMT May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has ...
Fri, 02 May 2025 06:38:00 GMT The information provided is based on a press release statement by ReShape Lifesciences. In other recent news, ReShape Lifesciences reported a notable decrease in revenue and gross profit for fiscal ...
